JHS Svendgaard Laboratories Ltd
JHS Svendgaard Laboratories Limited is engaged in manufacturing a range of oral and dental products for elite national and international brands. [1]
- Market Cap ₹ 110 Cr.
- Current Price ₹ 17.0
- High / Low ₹ 28.1 / 13.6
- Stock P/E 68.4
- Book Value ₹ 26.6
- Dividend Yield 0.00 %
- ROCE -1.18 %
- ROE 0.90 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.67 times its book value
- Debtor days have improved from 123 to 78.4 days.
- Company's working capital requirements have reduced from 184 days to 51.5 days
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -7.27% over past five years.
- Company has a low return on equity of -0.14% over last 3 years.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Personal Care - Indian
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
127 | 60 | 35 | 55 | 100 | 104 | 140 | 124 | 139 | 101 | 86 | 96 | |
110 | 48 | 39 | 59 | 93 | 92 | 126 | 124 | 137 | 99 | 87 | 105 | |
Operating Profit | 16 | 12 | -4 | -4 | 7 | 12 | 14 | 0 | 2 | 2 | -1 | -9 |
OPM % | 13% | 20% | -11% | -7% | 7% | 11% | 10% | 0% | 1% | 2% | -1% | -9% |
1 | 12 | -3 | -6 | -17 | 0 | 32 | 6 | 3 | 7 | 9 | -4 | |
Interest | 6 | 10 | 14 | 0 | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
Depreciation | 7 | 14 | 15 | 12 | 10 | 6 | 7 | 7 | 9 | 7 | 7 | 7 |
Profit before tax | 3 | 0 | -35 | -22 | -22 | 5 | 38 | -2 | -6 | 1 | 0 | -22 |
Tax % | 66% | 1,357% | 18% | -0% | 0% | -327% | 32% | 19% | 17% | -39% | 4,000% | 23% |
Net Profit | 1 | -4 | -29 | -22 | -22 | 22 | 26 | -2 | -5 | 1 | -4 | -17 |
EPS in Rs | 0.63 | -1.56 | -11.96 | -9.21 | -5.75 | 4.97 | 4.29 | -0.11 | -0.33 | 0.19 | -0.62 | -2.38 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 5% |
5 Years: | -7% |
3 Years: | -12% |
TTM: | 12% |
Compounded Profit Growth | |
---|---|
10 Years: | 8% |
5 Years: | -27% |
3 Years: | 1% |
TTM: | 145% |
Stock Price CAGR | |
---|---|
10 Years: | 4% |
5 Years: | -18% |
3 Years: | 10% |
1 Year: | -32% |
Return on Equity | |
---|---|
10 Years: | -1% |
5 Years: | 0% |
3 Years: | 0% |
Last Year: | 1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
18 | 24 | 24 | 24 | 38 | 44 | 61 | 61 | 61 | 64 | 65 | 65 | |
Reserves | 97 | 65 | 38 | 96 | 57 | 86 | 113 | 116 | 117 | 124 | 121 | 108 |
67 | 101 | 54 | 19 | 3 | 2 | 2 | 7 | 9 | 7 | 6 | 3 | |
52 | 41 | 74 | 33 | 25 | 23 | 32 | 39 | 55 | 33 | 30 | 60 | |
Total Liabilities | 233 | 232 | 190 | 171 | 122 | 155 | 208 | 223 | 241 | 228 | 222 | 236 |
52 | 135 | 121 | 108 | 65 | 65 | 71 | 71 | 66 | 63 | 59 | 66 | |
CWIP | 24 | 0 | 0 | 0 | 1 | 1 | 1 | 5 | 7 | 9 | 20 | 9 |
Investments | 0 | 0 | 0 | 0 | 0 | 1 | 18 | 10 | 6 | 2 | 4 | 4 |
157 | 97 | 70 | 63 | 57 | 89 | 118 | 137 | 163 | 154 | 140 | 157 | |
Total Assets | 233 | 232 | 190 | 171 | 122 | 155 | 208 | 223 | 241 | 228 | 222 | 236 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-12 | 60 | 28 | 7 | -4 | -4 | 14 | -11 | 10 | 12 | -9 | 19 | |
-26 | -22 | 3 | 1 | 1 | -3 | -27 | -7 | -11 | -2 | -5 | 6 | |
37 | -39 | -29 | -10 | 4 | 10 | 14 | 13 | 0 | 10 | -2 | 8 | |
Net Cash Flow | -1 | -2 | 2 | -1 | 2 | 3 | 0 | -5 | -0 | 20 | -16 | 33 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 295 | 220 | 188 | 167 | 25 | 48 | 111 | 158 | 252 | 213 | 77 | 78 |
Inventory Days | 54 | 132 | 122 | 94 | 53 | 95 | 65 | 60 | 30 | 97 | 114 | 76 |
Days Payable | 180 | 407 | 95 | 106 | 67 | 123 | 153 | 134 | 177 | 128 | 130 | 118 |
Cash Conversion Cycle | 170 | -55 | 215 | 156 | 12 | 19 | 23 | 85 | 105 | 182 | 61 | 36 |
Working Capital Days | 201 | 29 | -368 | 84 | 59 | 56 | 122 | 187 | 202 | 277 | 222 | 52 |
ROCE % | 6% | 1% | -10% | -12% | -3% | 5% | 8% | -0% | 4% | 1% | 1% | -1% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
18h - Transcript of the Conference Call held to discuss Financial Results for the quarter and year ended on 31st March, 2023
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1 Jun - Newspaper publication of Audited (Standalone and Consolidated) Financial results for the quarter and year ended March 31, 2023.
- Please Find Enclosed Audio Recording Of The Conference Call For Analysts And Investors Held On May 31St, 2023. 1 Jun
-
Announcement under Regulation 30 (LODR)-Investor Presentation
31 May - Presentation on the Audited Financial Results of JHS Svendgaard Laboratories Limited for the quarter and year ended on 31st March 2023.
- Announcement Under Regulation 30- Related Party Transaction For The Half Year Ended March 31, 2023 30 May
Annual reports
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
-
Financial Year 2010
from bse
-
Financial Year 2010
from nse
Concalls
-
Jun 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
Jun 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
Products
The company’s product portfolio includes Toothbrush, Toothpaste, Mouthwash, Laundry detergent, Hand sanitizer, soap bars, shampoos, handwashes, cream, snacks, talcum powder and washing powder. [1]